Yarrow — Benefits Deep Dive

Yarrow (Achillea millefolium) is one of the most heavily documented medicinal plants in the European record and one of the least tested. Its genus name honours Achilles; its folk names — soldier's woundwort, staunchweed, nosebleed plant — all describe a single use; and its traditional indications run to dozens across European and North American ethnobotany. Set that beside the modern literature and the contrast is startling: a handful of small human trials, a scattering of animal studies, and a great deal of test-tube chemistry. Applequist and Moerman put the point in their review's subtitle — "A Neglected Panacea?"

These four pages take yarrow's main claims one at a time and label each one's evidence tier honestly, because the tiers differ far more than most writing about the plant admits. The wound and bleeding claim, its most famous, is the weakest: traditional plus preclinical, with no adequate controlled human trial. The digestive and bitter use has the most coherent mechanism, a plausible physiological route through the cephalic phase of digestion, and a German Commission E monograph — which rests largely on tradition rather than on trial results, and this hub says so. The menstrual use has the best actual evidence of anything yarrow does: one small double-blind, placebo-controlled randomized trial. And the safety page is the one usually skipped and the one that most changes what a reader should do, because yarrow contains thujone, cross-reacts with ragweed and chamomile allergy, is contraindicated in pregnancy, and carries a bleeding-drug and epilepsy caution.

The tradition is treated here with respect — it is genuinely interesting history and a real body of human knowledge. It is also, on its own, history rather than evidence, and these pages keep those two things in separate columns.

Table of Contents

1. Deep-Dive Articles
2. Yarrow's Evidence at a Glance
3. How to Read an Evidence Tier
4. Key Research: Wounds and Bleeding
5. Key Research: Bitters and Digestion
6. Key Research: Menstrual and Pelvic Use
7. Key Research: Thujone, Allergy and Interactions
8. Key Research: Chemistry, Chemotypes and Identity
9. External Resources
10. Connections

Deep-Dive Articles

Back to Table of Contents

Yarrow's Evidence at a Glance

Ranked from best-supported to worst, which is very nearly the reverse of how popular sources rank them:

1. Primary period pain — one randomized, double-blind, placebo-controlled trial reporting reduced pain, unreplicated. Yarrow's strongest single result.
2. Chemotherapy-induced oral mucositis — one double-blind randomized controlled trial of a yarrow mouthwash reporting reduced severity. Specific population, specific condition, but properly controlled.
3. Appetite loss and dyspeptic complaints — traditional use with a plausible, partly human-confirmed bitter mechanism, plus a Commission E monograph resting largely on tradition. No trial of yarrow itself.
4. Digestive and menstrual cramping — preliminary: isolated-tissue antispasmodic activity consistent with calcium-channel blockade, plus anti-inflammatory activity in laboratory models.
5. Gastroprotection — preliminary, animal: rat antiulcer studies with a reassuring chronic-safety component. Not a treatment for human gastritis or ulcer.
6. Wound healing — traditional plus preclinical: animal and in-vitro results, one randomized human trial of a two-herb ointment that cannot isolate yarrow's contribution.
7. Fevers and colds — traditional use only. A hot drink and rest are doing recognisable work here.
8. Stopping bleeding — traditional, plus a single old animal report on an isolated alkaloid. Contradicted within the same literature by a theoretical antiplatelet effect. No human evidence.
9. Heavy menstrual bleeding, endometriosis, fibroids, PMS, pelvic infection — no evidence at any tier, and in several cases a real cost to delaying proper treatment.

The three genuinely well-established facts about yarrow are all on the safety side: it contains thujone, it is a documented contact sensitizer with characterized culprit compounds, and it is contraindicated in pregnancy.

Back to Table of Contents

How to Read an Evidence Tier

Every claim across these four pages is labelled with one of four tiers. They are not interchangeable, and collapsing them is how herbal writing goes wrong.

• Randomized clinical trial. Humans, allocated by chance, ideally with neither participant nor assessor knowing who got what. The only tier that reliably separates a treatment effect from natural recovery, expectation and attention.
• Other human study. Uncontrolled series and before-and-after observation. Good for safety signals, weak for efficacy.
• Preliminary — animal or in vitro. Rats, cell cultures, bacterial plates, organ baths. Real science, genuinely informative about mechanism, and routinely over-read. Most positive yarrow findings live here.
• Traditional use only. The historical and ethnobotanical record. Valuable as history and as a source of research leads. Not a measurement of anything.

Two recurring traps are worth naming. A regulatory monograph is not a trial result — Commission E approval and the European "traditional use" registration category both explicitly rest on long use plus acceptable safety, and the European system requires products to say so on the label. And age of tradition does not accumulate into evidence: two thousand years of confident use is two thousand years of uncontrolled observation, which is why the herbs with the longest reputations are often the ones whose trials, when finally run, come out flat.

Back to Table of Contents

Key Research: Wounds and Bleeding

Links are PubMed topic searches so the results stay current; titles, journals and years are given so you can find the specific paper. Full discussion on the wounds and bleeding page.

1. Applequist WL, Moerman DE. "Yarrow (Achillea millefolium L.): A Neglected Panacea? A Review of Ethnobotany, Bioactivity, and Biomedical Research." Economic Botany, 2011. PubMed: Achillea millefolium ethnobotany review
2. Ghasemi MR, Ranjbar A, Tamri P, et al. "In vitro Antibacterial Activity and Wound Healing Effects of Achillea millefolium Essential Oil in Rat." Journal of Pharmacopuncture, 2023. PubMed: Achillea millefolium essential oil wound healing rat
3. Hajhashemi M, et al. "The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women." Journal of Maternal-Fetal & Neonatal Medicine, 2018 — randomized, but a two-herb combination. PubMed: Achillea millefolium episiotomy wound healing
4. Miranzadeh S, Adib-Hajbaghery M, Soleymanpoor L, Ehsani M. "Effect of adding the herb Achillea millefolium on mouthwash on chemotherapy induced oral mucositis in cancer patients: A double-blind randomized controlled trial." European Journal of Oncology Nursing, 2015. PubMed: Achillea millefolium oral mucositis randomized
5. Dorjsembe B, et al. "Achillea asiatica extract and its active compounds induce cutaneous wound healing." Journal of Ethnopharmacology. PubMed: Achillea asiatica cutaneous wound healing
6. Miller FM, Chow LM. "Alkaloids of Achillea millefolium L. I. Isolation and Characterization of Achilleine." Journal of the American Chemical Society, 1954 — the single report behind the haemostatic-alkaloid claim. PubMed: achilleine betonicine Achillea
7. Solecki RS. "Shanidar IV, a Neanderthal Flower Burial in Northern Iraq." Science, 1975; with Sommer JD. "The Shanidar IV 'Flower Burial': A Re-evaluation of Neanderthal Burial Ritual." Cambridge Archaeological Journal, 1999 — the claim and the rodent-caching critique. PubMed: Shanidar Neanderthal burial

Back to Table of Contents

Key Research: Bitters and Digestion

Full discussion on the digestion and bitter action page.

1. Yaeesh S, Jamal Q, Khan AU, Gilani AH. "Studies on hepatoprotective, antispasmodic and calcium antagonist activities of the aqueous-methanol extract of Achillea millefolium." Phytotherapy Research, 2006. PubMed: Achillea millefolium antispasmodic calcium antagonist
2. Potrich FB, Allemand A, da Silva LM, et al. "Antiulcerogenic activity of hydroalcoholic extract of Achillea millefolium L.: involvement of the antioxidant system." Journal of Ethnopharmacology, 2010. PubMed: Achillea millefolium antiulcerogenic antioxidant
3. Andreozzi P, Sarnelli G, Pesce M, et al. "The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects." Journal of Neurogastroenterology and Motility, 2015. PubMed: bitter taste receptor quinine cholecystokinin humans
4. Rezaie P, Bitarafan V, Horowitz M, Feinle-Bisset C. "Effects of bitter substances on gastrointestinal function, energy intake and glycaemia — do preclinical findings translate to outcomes in humans?" Nutrients, 2021. PubMed: bitter substances gastrointestinal function review
5. McMullen MK, Whitehouse JM, Towell A. "Bitters: Time for a New Paradigm." Evidence-Based Complementary and Alternative Medicine, 2015. PubMed: bitters new paradigm vagal digestive
6. Power ML, Schulkin J. "Anticipatory physiological regulation in feeding biology: cephalic phase responses." Appetite, 2008. PubMed: cephalic phase response digestion review
7. Behrens M, Meyerhof W. "Bitter taste receptors and human bitter taste perception." Cellular and Molecular Life Sciences, 2006 — the TAS2R family, including extra-oral expression. PubMed: TAS2R bitter taste receptor extraoral expression

Back to Table of Contents

Key Research: Menstrual and Pelvic Use

Full discussion on the menstrual and pelvic page.

1. Jenabi E, Fereidoony B. "Effect of Achillea millefolium on relief of primary dysmenorrhea: a double-blind randomized clinical trial." Journal of Pediatric and Adolescent Gynecology, 2015 — yarrow's best single result. PubMed: Achillea millefolium primary dysmenorrhea randomized
2. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. "Nonsteroidal anti-inflammatory drugs for dysmenorrhoea." Cochrane Database of Systematic Reviews — the benchmark. PubMed: NSAIDs dysmenorrhoea Cochrane review
3. Pattanittum P, Kunyanone N, Brown J, et al. "Dietary supplements for dysmenorrhoea." Cochrane Database of Systematic Reviews. PubMed: dietary supplements dysmenorrhoea Cochrane
4. Daily JW, Zhang X, Kim DS, Park S. "Efficacy of ginger for alleviating the symptoms of primary dysmenorrhea: a systematic review and meta-analysis of randomized clinical trials." Pain Medicine, 2015 — the herb with better data than yarrow. PubMed: ginger primary dysmenorrhea meta-analysis
5. Reviews of prostaglandin release and uterine contractility in dysmenorrhoea — the mechanism any cramping remedy has to engage. PubMed: prostaglandins uterine contractility dysmenorrhea
6. Literature on local heat application for menstrual pain — relevant because traditional preparations deliver heat too. PubMed: heat therapy menstrual pain randomized

Back to Table of Contents

Key Research: Thujone, Allergy and Interactions

Full discussion on the safety page, which is the one to read first.

1. Höld KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE. "α-Thujone (the active component of absinthe): γ-aminobutyric acid type A receptor modulation and metabolic detoxification." Proceedings of the National Academy of Sciences, 2000. PubMed: alpha-thujone GABA receptor absinthe
2. Lachenmeier DW, Uebelacker M. "Risk assessment of thujone in foods and medicines containing sage and wormwood — evidence for a need of regulatory changes?" Regulatory Toxicology and Pharmacology, 2010. PubMed: thujone risk assessment sage wormwood
3. Hausen BM, Breuer J, Weglewski J, Rücker G. "α-Peroxyachifolid and other new sensitizing sesquiterpene lactones from yarrow (Achillea millefolium L., Compositae)." Contact Dermatitis, 1991. PubMed: Achillea millefolium sensitizing sesquiterpene lactones
4. Paulsen E. "Contact sensitization from Compositae-containing herbal remedies and cosmetics." Contact Dermatitis, 2002; and "Compositae dermatitis: a survey." Contact Dermatitis, 1992. PubMed: Compositae dermatitis herbal remedies cosmetics
5. Spinella M. "Herbal medicines and epilepsy: the potential for benefit and adverse effects." Epilepsy & Behavior, 2001. PubMed: herbal medicine epilepsy seizure threshold
6. Izzo AA, Ernst E. "Interactions between herbal medicines and prescribed drugs: an updated systematic review." Drugs, 2009; and Ge B, Zhang Z, Zuo Z. "Updates on the clinical evidenced herb-warfarin interactions." Evidence-Based Complementary and Alternative Medicine, 2014. PubMed: herb warfarin interaction clinical evidence
7. Cavalcanti AM, Baggio CH, Freitas CS, et al. "Safety and antiulcer efficacy studies of Achillea millefolium L. after chronic treatment in Wistar rats." Journal of Ethnopharmacology, 2006 — a rare chronic-dosing safety assessment. PubMed: Achillea millefolium chronic toxicity safety rats

Back to Table of Contents

Key Research: Chemistry, Chemotypes and Identity

Why two samples of "yarrow" are not the same substance — the thread that runs through all four pages.

1. Ali SI, Gopalakrishnan B, Venkatesalu V. "Pharmacognosy, Phytochemistry and Pharmacological Properties of Achillea millefolium L.: A Review." Phytotherapy Research, 2017. PubMed: Achillea millefolium phytochemistry review
2. Chandler RF, Hooper SN, Harvey MJ. "Ethnobotany and phytochemistry of yarrow, Achillea millefolium, Compositae." Economic Botany, 1982 — the classic account linking folk use to chemistry. PubMed: Achillea millefolium ethnobotany phytochemistry
3. Benedek B, Kopp B. "Achillea millefolium L. s.l. revisited: Recent findings confirm the traditional use." Wiener Medizinische Wochenschrift, 2007 — and the companion paper on protease inhibition in the Journal of Ethnopharmacology, 2007. PubMed: Achillea millefolium anti-inflammatory protease inhibition
4. Candan F, Unlu M, Tepe B, et al. "Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae)." Journal of Ethnopharmacology, 2003. PubMed: Achillea millefolium antioxidant antimicrobial essential oil
5. El-Kalamouni C, Venskutonis PA, Zebib B, et al. "Antioxidant and Antimicrobial Activities of the Essential Oil of Achillea millefolium L. Grown in France." Medicines, 2017 — how much origin changes the oil. PubMed: Achillea millefolium essential oil composition variability
6. Nemeth E, Bernath J. "Biological Activities of Yarrow Species (Achillea spp.)." Current Pharmaceutical Design, 2008 — genus-wide survey. PubMed: Achillea species biological activities
7. Work on the Achillea millefolium aggregate, ploidy level and proazulene production — why only some yarrow yields blue chamazulene. PubMed: Achillea millefolium aggregate ploidy proazulene

Back to Table of Contents

External Resources

Stable, non-commercial starting points. Deep links inside these sites move; these are the landing pages.

• NIH National Center for Complementary and Integrative Health — plain-language, sceptical evidence summaries for herbs and supplements.
• PubMed — the primary biomedical literature. Every citation above links to a topic search here.
• European Medicines Agency — the herbal monograph system, the "traditional use" registration category, and the public statement on thujone-containing herbal products.
• NIH Office of Dietary Supplements — how supplements are regulated, and why label quality varies.
• Plants of the World Online (Kew) — authoritative nomenclature for Achillea millefolium and the ornamental hybrids.
• USDA PLANTS Database — distribution and identification of yarrow across North America.
• MedlinePlus — patient-level information on wound care, indigestion and menstrual problems.
• Poison Control (US) — first stop for an essential-oil ingestion.

Back to Table of Contents

Connections

• All Herbs
• Yarrow — the main topic page: botany, folklore, compounds, forms
• Yarrow for Wounds and Bleeding — the famous claim, honestly tiered
• Yarrow for Digestion — the best-reasoned use
• Yarrow for Menstrual Complaints — the one randomized trial
• Yarrow Safety — thujone, allergy, pregnancy, epilepsy, drug interactions
• Wormwood — the archetypal thujone bitter
• Wormwood Benefits — same caution class, higher stakes
• Sage — the other everyday thujone herb
• Sage Benefits — thujone in a culinary plant
• Chamomile — daisy-family relative and the other chamazulene source
• Chamomile Benefits — the gentler Asteraceae option
• Calendula — the classic daisy-family skin herb
• Calendula Benefits — better topical evidence than yarrow
• Feverfew — sesquiterpene lactones and the same allergy caution
• Chrysanthemum — classic Compositae contact allergen
• Mugwort — cross-reacting Asteraceae pollen allergen
• Dandelion — bitter Asteraceae digestive herb
• Dandelion Benefits — the bitter and bile claims examined
• Echinacea — daisy-family immune herb, same allergy caution
• Comfrey — traditional bruise herb with a serious internal-use warning
• Plantain — the other roadside first-aid poultice
• Self-Heal — a wound herb whose name makes the same promise
• Agrimony — astringent traditional bleeding-and-wound herb
• Ginger — better dysmenorrhoea and nausea evidence
• Peppermint — the antispasmodic with the strongest trials
• Elderberry & Elderflower — traditional partner in yarrow fever teas
• Milk Thistle — the better-studied liver herb
• Contact Dermatitis — the documented yarrow reaction
• Functional Dyspepsia — the complaint bitters target
• Dysmenorrhea — the physiology behind the cramping claim
• Epilepsy — why thujone matters clinically
• Allergies — how Asteraceae cross-reactivity works

Back to Table of Contents

Safety and disclaimer. These pages are educational and are not medical advice. Yarrow's traditional record is long and its clinical evidence is thin: its best-supported use rests on a single small randomized trial, and its most famous use — stopping bleeding and healing wounds — has no adequate controlled human trial behind it at all. Yarrow contains thujone, so use modest amounts in short courses and never swallow the essential oil. Do not use it in pregnancy or while breastfeeding. Avoid it if you have epilepsy or react to ragweed, mugwort, chamomile, feverfew, chrysanthemum or calendula. Check with a prescriber or pharmacist before combining it with anticoagulant, antiplatelet, sedative or blood-pressure medication, and stop it before surgery. Any symptom that is new, severe, worsening or unexplained needs medical assessment, not a herb.